Related Experiment Video
Updated: Apr 19, 2026

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
MicroRNA-21: a central regulator of fibrotic diseases via various targets
1School of Pharmacy, Anhui Medical University, Mei Shan Road, Hefei, Anhui Province, 230032, China. kaoyan110@126.com.
Abstract:
MicroRNAs (miRNAs) are small non-coding RNA molecules that diversely regulate physiological and pathophysiological processes by specifically binding to different regions of targeting messenger RNAs (mRNAs). Fibrosis is characterized by the abnormal proliferation of fibroblasts and the deposition of the extracellular matrix (ECM). Both clinical and experimental animal studies have revealed that aberrant expression of miRNAs is closely associated with the development of fibrotic diseases. microRNA-21 (miR-21) is a ubiquitously expressed miRNA that is traditionally considered to be an oncogenic miRNA (oncomiR). Recent studies have demonstrated that elevated expression of miR-21 may play a vital role in the development of fibrosis by promoting the proliferation of interstitial fibroblasts and increasing the abnormal deposition of the ECM. In this review, we comprehensively summarize the role of miR-21 in tissue fibrosis. Furthermore, we highlight miR-21 as a potential diagnostic and prognostic marker and therapeutic target for fibrosis diseases.
Insights
MicroRNA-21 (miR-21) promotes fibrosis by increasing fibroblast proliferation and extracellular matrix deposition. This review explores miR-21
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression.
- Fibrosis involves fibroblast proliferation and extracellular matrix (ECM) deposition.
- Aberrant miRNA expression is linked to fibrotic disease development.
Purpose of the Study:
- To comprehensively review the role of microRNA-21 (miR-21) in tissue fibrosis.
- To highlight miR-21 as a potential diagnostic, prognostic, and therapeutic target for fibrosis.
Main Methods:
- Literature review of clinical and experimental studies on miR-21 and fibrosis.
- Analysis of miR-21's regulatory mechanisms in fibroblast proliferation and ECM deposition.
Main Results:
- Elevated miR-21 expression is associated with increased interstitial fibroblast proliferation.
- miR-21 promotes abnormal extracellular matrix deposition, contributing to fibrosis.
- miR-21 is increasingly recognized for its role beyond oncogenesis in fibrotic diseases.
Conclusions:
- MicroRNA-21 plays a significant role in the pathogenesis of various fibrotic diseases.
- miR-21 presents potential as a biomarker for diagnosing and predicting fibrosis.
- Targeting miR-21 offers a promising therapeutic strategy for managing fibrotic conditions.
Related Concept Videos
Master Transcription Regulators
MicroRNAs
MicroRNAs
MicroRNAs
Abnormal Proliferation
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...

